Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL2 inhibitor venetoclax in AML

Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML

20:24 EDT 7 Jun 2019 | Nature Publishing

More From BioPortfolio on "Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML"